You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Mallinckrodt
Boehringer Ingelheim
McKinsey
Dow

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

Patent: 10,322,162

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,322,162
Title:Methods and pharmaceutical compositions for the treatment of ischemic conditions
Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of ischemic conditions. In particular, the present invention relates to a method of treating an ischemic condition in a subject in need thereof comprising administering the subject with a polypeptide comprising an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino acid residue at position 186 to the amino acid residue at position 406 in SEQ ID NO: 1.
Inventor(s): Germain; Stephane (Paris, FR), Berdeaux; Alain (Creteil, FR), Tissier; Renaud (Creteil, FR), Ghaleh-Marzban; Bijan (Creteil, FR), Monnot; Catherine (Paris, FR), Galaup; Ariane (Paris, FR)
Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) (Paris, FR) ECOLE NATIONALE VETERINAIRE D\'ALFORT (ENVA) (Maisons-Alfort, FR)
Application Number:15/541,422
Patent Claims:see list of patent claims

Details for Patent 10,322,162

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 001 1987-11-13   Start Trial INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI 2035-01-06 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 002 1987-11-13   Start Trial INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI 2035-01-06 RX search
Genentech CATHFLO ACTIVASE alteplase VIAL 103172 003 1987-11-13   Start Trial INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI 2035-01-06 RX search
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Start Trial INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) COLLEGE DE FRANCE (Paris, FR) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Creteil, FR) UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (Creteil, FR) ASSI 2035-01-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Boehringer Ingelheim
Colorcon
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.